Figure 3.
Kaplan-Meier survival curves depicting all-cause mortality at 1-year after IMI diagnosis in patients: A, administration of an allogeneic HCT or not (log-rank test, P = .01); B, center (log-rank test, P = .28). CHUV, University Hospital of Lausanne; HCT, hematopoietic cell transplant; HUG, University Hospital of Geneva; USB, University Hospital of Basel.

Kaplan-Meier survival curves depicting all-cause mortality at 1-year after IMI diagnosis in patients: A, administration of an allogeneic HCT or not (log-rank test, P = .01); B, center (log-rank test, P = .28). CHUV, University Hospital of Lausanne; HCT, hematopoietic cell transplant; HUG, University Hospital of Geneva; USB, University Hospital of Basel.

Close
This Feature Is Available To Subscribers Only

Sign In or Create an Account

Close

This PDF is available to Subscribers Only

View Article Abstract & Purchase Options

For full access to this pdf, sign in to an existing account, or purchase an annual subscription.

Close